OSM-DAN LTD

Their core work

OSM-DAN is an Israeli SME specializing in nanotechnology and advanced materials processing, based in Rehovot — a city known for its proximity to the Weizmann Institute. They contribute materials science and nano-engineering expertise to EU consortia across diverse application domains, from antimicrobial surface treatments and bio-based composites to medical imaging and diagnostics. Their recurring role is translating nano-scale material innovations into functional products for industry, whether that means nanostructured textiles, bio-based foams, or nano-enabled diagnostic platforms.

What they specialise in

How they've shifted over time

OSM-DAN's early H2020 work (2017-2018) centered on industrial applications of nanomaterials — antimicrobial textile coatings (PROTECT) and bio-based construction materials (ReInvent). From 2018 onward, they diversified into medical diagnostics (EDIT, with photoacoustic imaging and nanomedicine for bladder cancer) and moved toward open innovation test beds with explicit nanosafety and standardization concerns (BIOMAT). The trajectory shows a company expanding from pure materials processing toward more regulated, higher-value domains where safety validation and industrial scaling matter.

OSM-DAN is moving toward regulated applications (medical, nanosafety) and pilot-line scaling, suggesting future interest in projects that bridge lab-scale nanomaterials with compliant industrial production.

How they like to work

OSM-DAN operates exclusively as a consortium participant, never leading projects — a pattern typical of specialized SMEs that bring deep technical capability rather than project management infrastructure. With 54 unique partners across just 4 projects (averaging ~14 partners per consortium), they consistently join large, multi-stakeholder Innovation Actions. This makes them an accessible partner: experienced in large consortia, comfortable in a contributor role, and unlikely to compete for coordination.

Despite only 4 projects, OSM-DAN has built a broad European network of 54 unique partners across 13 countries, reflecting participation in large Innovation Action consortia that span multiple EU member states.

What sets them apart

OSM-DAN brings an unusual combination: nano-materials expertise applied across both industrial (textiles, composites, foams) and biomedical (cancer diagnostics) domains. As an Israeli SME embedded in the Rehovot research ecosystem, they offer a non-EU perspective with strong ties to European consortia. Their experience spans the full path from nanoparticle engineering to pilot-line production, making them valuable for projects that need to move nanomaterials from the lab toward market-ready products.

Highlights from their portfolio

• BIOMAT
  Largest single grant (EUR 510K) and most recent project, focused on an open innovation test bed — indicates growing role in industrial scaling of nano-enabled bio-based materials.
• EDIT
  Most technically distinctive project, combining photoacoustic imaging, ultrasound, and nanomedicine for non-invasive bladder cancer diagnostics — a significant departure from their industrial materials work.
• PROTECT
  First H2020 project, establishing their core competence in nanostructured surface treatments with a clear pre-commercial manufacturing focus.